Enjoy complimentary customisation on priority with our Enterprise License!
The preclinical respiration and inhalation lab equipment market size is forecast to increase by USD 4.16 million, at a CAGR of 4.29% between 2023 and 2028
There has been an increase in research on respiratory diseases across the globe. In addition, the market is witnessing an increase in respiratory research, which can be attributed to the growing investments in R&D activities focused on respiratory diseases. Furthermore, substantial advances have been made toward understanding the basic mechanisms of pulmonary diseases as well as optimizing their clinical management, as respiratory diseases are a major public health concern globally. Hence, such factors are positively impacting the market.
Technavio has segmented the market into Type, End-user, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The respiration equipment segment is estimated to witness significant growth during the forecast period. Respiration equipment is referred to as a collection of instruments and gadgets used to measure, track, and examine respiratory parameters in living things. In addition, this apparatus is frequently used to evaluate different facets of respiratory function in scientific, medical, and preclinical research contexts.
Get a glance at the market contribution of various segments Download PDF Sample
The respiration equipment segment was the largest segment and was valued at USD 12.93 billion in 2018. Moreover, devices for measuring tidal volume, respiratory rate, minute ventilation, and gas exchange are examples of equipment used in respiration measurements. In addition, it might also entail using specialized equipment to perform experiments on respiratory physiology and pathology, evaluate lung function, and investigate the effects of substances inhaled. Furthermore, research on respiratory health in general, drug development, inhalation toxicology studies, and respiratory diseases all greatly benefit from the equipment. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Preclinical respiration and inhalation lab equipment are extensively adopted for respiratory research as well as drug discovery. In addition, several pharmaceutical companies, big and small, have been outsourcing work to contract research organizations (CROs), while academic institutes that lack the infrastructure or equipment for performing certain tasks, also depend on outsourcing. Moreover, several academic institutes also prefer to perform all the preclinical respiratory research-related tasks on their premises for better monitoring and control over experiments. Furthermore, biopharmaceutical companies are increasingly dependent on CROs for services in the areas of preclinical and clinical research as well as drug discovery due to the high pressure on them to improve the productivity of their R&D activities. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
Some of the major pharmaceutical and biotechnology companies have developed the infrastructure needed to conduct experiments/research related to drug discovery as well as preclinical and clinical studies, due to the lack of a robust structural framework among CROs, which are not equipped enough to meet the rising demand from them. In addition, many major pharmaceutical companies that work on medicines to treat respiratory conditions acquire small-scale CROs to perform in-house respiratory-related research activities. Moreover, factors such as adverse working conditions and the increasing number of underpaid staff in the facilities of numerous CROs are facilitating pharmaceutical and biotechnology companies to opt to conduct respiratory-related research activities in their premises. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 48% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The large market share of North America in 2023 in the global preclinical respiration and inhalation lab equipment market is fuelled by the rising spending on R&D, the increasing focus on respiratory research, and the presence of key market players with their headquarters in the region. In addition, in North America, a significant number of people suffer from respiratory disorders, such as asthma, COPD, lung cancer, pneumonia, and chronic sinusitis.
Moreover, most of these respiratory diseases are primarily caused by genetic mutations and medical history, dust, air pollution, tobacco smoke, and occupational chemicals. Therefore., this has led to a substantial demand for respiratory research, which, in turn, has resulted in a rapid rise in the R&D expenditure on respiratory research to study pulmonary function. Hence, such factors are driving the market growth in North America during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 17 market companies, including:
4DMedical Ltd: The company offers preclinical respiration and inhalation lab equipment namely XV Technology. Additionally, XY technology can be used for imaging lung function by using hospital imaging systems and X ray images from different angles.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the preclinical respiration and inhalation lab equipment market growth is the growing prevalence of respiratory disorders. Chronic respiratory diseases, including chronic obstructive respiratory disease (COPD) and asthma, affect the airways and lungs. In addition, they are primarily caused by dust, air pollution, tobacco smoke, and exposure to occupational chemicals. Furthermore, patients with chronic respiratory diseases, such as COPD and asthma, are advised to undergo continuous monitoring to identify the associated risks.
Moreover, the prevalence of chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD) and asthma, is increasing across the globe. In addition, the prevalence of respiratory diseases, such as asthma and COPD, is specifically high among geriatric people as the strength of the respiratory muscles declines with age. Furthermore, the risks associated with respiratory disorders, such as diabetes, smoking, and obesity, are also on the rise. Hence, such factors are driving the market growth during the forecast period.
A key factor shaping the preclinical respiration and inhalation lab equipment market growth is the growing popularity of minimally invasive techniques in respiratory research. With the increasing prevalence of respiratory disorders, including asthma, COPD, and infectious respiratory diseases, more research on lung function is becoming essential for drug discovery as well as other purposes. In addition, pulmonary function is a relevant endpoint in both pharmacological and toxicological studies on respiratory diseases.
Moreover, the assessment of drug effects on vital organ systems, such as the respiratory system, requires the use of non-invasive or minimally invasive techniques in conscious rodents, where the use of anesthesia is not necessary. Therefore, minimally invasive techniques are gaining prominence in respiratory research. Hence, such factors are driving the market growth during the forecast period.
Limitations of animal studies are one of the key challenges hindering the preclinical respiration and inhalation lab equipment market growth. Although animal specimens are often beneficial and are increasingly utilized in respiratory research, there are various limitations to animal studies. In addition, one of the major limitations that scientists face during respiratory research is the inability to replicate animal studies in human trials.
Moreover, this can be attributed to the poor design of the procedures in experiments, the choice of incorrect approaches while conducting the procedures in the lab environment, or the inaccurate analysis of the measurements. Furthermore, animal specimens, such as mice, offer promising potential for assessing the effects of drugs, mediators, and infectious agents on the human lungs and their function. Hence, such factors are negatively impacting the market which in turn hinders the market growth during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Preclinical Respiration and Inhalation Lab Equipment Market Customer Landscape
The preclinical respiration and inhalation lab equipment market report forecasts market growth analysis by revenue at global, regional & country levels and provides an analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028.
Preclinical Respiration and Inhalation Lab Equipment Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.29% |
Market Growth 2024-2028 |
USD 4.16 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
3.65 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 48% |
Key countries |
US, Germany, France, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
4DMedical Ltd, ADInstruments Pty Ltd., Bruker Corp., CH Technologies USA Inc., Columbus Instruments LLC, CWE, emka TECHNOLOGIES, EMMS, Harvard Bioscience Inc., IN TOX PRODUCTS LLC, Kent Scientific Corp., Koninklijke Philips N.V., Lab Products Inc., NuAire Inc., TSE Systems GmbH, Vivotecnia, and RWD Life Science Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.